These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24776894)

  • 1. Combined drug and surgery treatment of plutonium-contaminated wounds: indications obtained using a rodent model.
    Griffiths NM; Coudert S; Wilk JC; Renault D; Angulo JF; Van der Meeren A
    Health Phys; 2014 Jun; 106(6):638-44. PubMed ID: 24776894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actinide handling after wound entry with local or systemic decorporation therapy in the rat.
    Griffiths NM; Coudert S; Renault D; Wilk JC; Van der Meeren A
    Int J Radiat Biol; 2014 Nov; 90(11):989-95. PubMed ID: 24456546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Internal contamination by actinides after wounding: a robust rodent model for assessment of local and distant actinide retention.
    Griffiths NM; Wilk JC; Abram MC; Renault D; Chau Q; Helfer N; Guichet C; Van der Meeren A
    Health Phys; 2012 Aug; 103(2):187-94. PubMed ID: 22951478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
    Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
    Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased retention of americium in kidneys as compared with plutonium in an actinide wound contamination model in the rat.
    Griffiths NM; Coudert S; Molina T; Wilk JC; Renault D; Berard P; Van der Meeren A
    Int J Radiat Biol; 2014 Nov; 90(11):1019-24. PubMed ID: 24650071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced decorporation of plutonium by DTPA encapsulated in small PEG-coated liposomes.
    Phan G; Le Gall B; Grillon G; Rouit E; Fouillit M; Benech H; Fattal E; Deverre JR
    Biochimie; 2006 Nov; 88(11):1843-9. PubMed ID: 16860919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo assessment of plutonium speciation and decorporation in blood and target retention tissues after a systemic contamination followed by an early treatment with DTPA.
    Sérandour AL; Grémy O; Fréchou M; Renault D; Poncy JL; Fritsch P
    Radiat Res; 2008 Aug; 170(2):208-15. PubMed ID: 18666819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CONRAD approach to biokinetic modeling of DTPA decorporation therapy.
    Breustedt B; Blanchardon E; Bérard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
    Health Phys; 2010 Oct; 99(4):547-52. PubMed ID: 20838097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling of bioassay data from a Pu wound treated by repeated DTPA perfusions: biokinetics and dosimetric approaches.
    Fritsch P; Grappin L; Guillermin AM; Fottorino R; Ruffin M; Mièle A
    Radiat Prot Dosimetry; 2007; 127(1-4):120-4. PubMed ID: 17562647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of diethylene triamine pentaacetic acid encapsulated in liposomes to rat liver: an effective strategy to prevent bone deposition and increase urine elimination of plutonium in rats.
    Phan G; Ramounet-Le Gall B; Manceau J; Fanet M; Benech H; Fritsch P; Fattal E; Deverre JR
    Int J Radiat Biol; 2004 Jun; 80(6):413-22. PubMed ID: 15362694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of wound intake of plutonium isotopes and 241Am in a human: application and improvement of the NCRP wound model.
    Schadilov AE; Belosokhov MV; Levina ES
    Health Phys; 2010 Oct; 99(4):560-7. PubMed ID: 20838099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Response, Dose Assessment, and Clinical Management of a Plutonium-contaminated Puncture Wound.
    Sugarman SL; Findley WM; Toohey RE; Dainiak N
    Health Phys; 2018 Jul; 115(1):57-64. PubMed ID: 29787431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biokinetic modelling of DTPA decorporation therapy: the CONRAD approach.
    Breustedt B; Blanchardon E; Berard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
    Radiat Prot Dosimetry; 2009 Feb; 134(1):38-48. PubMed ID: 19351653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Local and Systemic DTPA Treatment Efficacy According to Actinide Physicochemical Properties Following Lung or Wound Contamination in the Rat.
    Griffiths NM; Van der Meeren A; Grémy O
    Front Pharmacol; 2021; 12():635792. PubMed ID: 33841153
    [No Abstract]   [Full Text] [Related]  

  • 15. Decorporation of Pu/Am Actinides by Chelation Therapy: New Arguments in Favor of an Intracellular Component of DTPA Action.
    Grémy O; Laurent D; Coudert S; Griffiths NM; Miccoli L
    Radiat Res; 2016 Jun; 185(6):568-79. PubMed ID: 27195610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium forms.
    Sérandour AL; Tsapis N; Gervelas C; Grillon G; Fréchou M; Deverre JR; Bénech H; Fattal E; Fritsch P; Poncy JL
    Radiat Prot Dosimetry; 2007; 127(1-4):472-6. PubMed ID: 17562654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct lung delivery of a dry powder formulation of DTPA with improved aerosolization properties: effect on lung and systemic decorporation of plutonium.
    Gervelas C; Serandour AL; Geiger S; Grillon G; Fritsch P; Taulelle C; Le Gall B; Benech H; Deverre JR; Fattal E; Tsapis N
    J Control Release; 2007 Mar; 118(1):78-86. PubMed ID: 17241685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of 3,4,3-LIHOPO for enhancing the excretion of plutonium from rat after simulated wound contamination as a tributyl-n-phosphate complex.
    Paquet F; Poncy JL; Metivier H; Grillon G; Fritsch P; Burgada R; Bailly T; Raymond KN; Durbin PW
    Int J Radiat Biol; 1995 Dec; 68(6):663-8. PubMed ID: 8551109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting plutonium decorporation efficacy after intravenous administration of DTPA formulations: Study of pharmacokinetic-pharmacodynamic relationships in rats.
    Phan G; Le Gall B; Deverre JR; Fattal E; Bénech H
    Pharm Res; 2006 Sep; 23(9):2030-5. PubMed ID: 16951998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decorporation approach following rat lung contamination with a moderately soluble compound of plutonium using local and systemic Ca-DTPA combined chelation.
    Grémy O; Tsapis N; Bruel S; Renault D; Van der Meeren A
    Radiat Res; 2012 Sep; 178(3):217-23. PubMed ID: 22799632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.